San Antonio Breast Cancer Symposium

January 10, 2018

Kisqali Granted Breakthrough Therapy Status to Treat Breast Cancer in Premenopausal Women

News

The U.S. Food and Drug Administration (FDA) has granted Kisqali (ribociclib) Breakthrough Therapy designation for the treatment of premenopausal women with HR-positive, HER2-negative advanced breast cancer who have not received prior endocrine ... Read more

January 5, 2018

Biannual MRI Better Than Annual Mammogram at Detecting Breast Cancer in High-risk Women, Study Finds

News

For young women with high genetic risk for breast cancer, intensive surveillance and examination by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) every six months is more effective for timely detection of ... Read more

December 2, 2014December 2, 2014

37th San Antonio Breast Cancer Symposium To Be Held December 9-13, 2014

News

The second week of December of every year holds a tradition for the breast cancer community that has been running for nearly 40 years, gathering thousands of the most prominent ... Read more

November 11, 2014November 19, 2014

Provista to Present Poster on Serum-Based Diagnostic for Breast Cancer

News

Molecular diagnostics company, Provista Diagnostics, Inc., recently announced their acceptance to present a poster at the upcoming San Antonio Breast Cancer Symposium, scheduled Tuesday, December 9 to Saturday, December 13, ... Read more